SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-23-000029
Filing Date
2023-08-02
Accepted
2023-08-02 12:48:35
Documents
71
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-20230630.htm   iXBRL 10-Q 1663587
2 EX-10.1 bmrn-exx101xq22023.htm EX-10.1 207187
3 EX-31.1 bmrn-exx311xq22023.htm EX-31.1 9250
4 EX-31.2 bmrn-exx312xq22023.htm EX-31.2 9240
5 EX-32.1 bmrn-exx321xq22023.htm EX-32.1 5134
  Complete submission text file 0001048477-23-000029.txt   7918242

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20230630.xsd EX-101.SCH 45081
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20230630_cal.xml EX-101.CAL 71443
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20230630_def.xml EX-101.DEF 229879
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20230630_lab.xml EX-101.LAB 621409
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20230630_pre.xml EX-101.PRE 398955
65 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20230630_htm.xml XML 1313112
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 231134637
SIC: 2834 Pharmaceutical Preparations